Liver News and Research

RSS

Study offers a new, effective therapeutic option against glioblastoma

A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.

22 Feb 2022

Covid still threatens millions of Americans. Why are we so eager to move on?

Iesha White is so fed up with the U.S. response to covid-19 that she's seriously considering moving to Europe.

22 Feb 2022

Livers of men with hepatic diseases undergo sex-change

The livers of men diagnosed with hepatic diseases change sex as part of a potential self-protective mechanism, according to University of Queensland research.

21 Feb 2022

The logic that controls gene regulation in human cells discovered

A research group at the University of Helsinki has discovered the logic that controls gene regulation in human cells. In the future, this new knowledge can be applied to, for example, investigating cancers and other genetic diseases.

21 Feb 2022

Poll: Most parents have limited knowledge about CBD products for children

Products containing cannabidiol (CBD), a chemical compound naturally found in marijuana and hemp, have been used in recent years to help adults manage medical issues like chronic pain and mood disorders.

21 Feb 2022

Treatment with direct-acting antivirals reduces emergency visits, hospitalizations among hepatitis C patients

Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver related health issues.

21 Feb 2022

Simplified model for describing biological tissue properties allows time and cost savings

Viscous mechanical properties of biological tissues can now be described more easily than before. This is shown by a recently published paper of a team of the Karl Landsteiner University of Health Sciences Krems.

21 Feb 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science's journal, Science Advances.

18 Feb 2022

Intermediate size nanoparticles may be effective at stopping internal bleeding

Traumatic injuries are the leading cause of death in the U.S. among people 45 and under, and such injuries account for more than 3 million deaths per year worldwide.

17 Feb 2022

Gut microbial signatures associated with increased risk of developing type 2 diabetes

A new study identified microbial signatures which predicted the onset of type 2 diabetes during nearly 16 years of follow-up in a large Finnish population cohort.

16 Feb 2022

Gut enzymes open a gateway to create universal blood-type donor organs

A study published in Science Translational Medicine performed at the Latner Thoracic Surgery Research Laboratories and UHN's Ajmera Transplant Centre has proved that it is possible to convert blood type safely in donor organs intended for transplantation.

16 Feb 2022

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects.

16 Feb 2022

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift from Richard Todd Stravitz, M.D., and his family's Barbara Brunckhorst Foundation.

15 Feb 2022

Study uncovers most critical genes that cause coronary heart disease

The most critical genes that cause coronary heart disease and trigger heart attacks have been identified in a major new study.

15 Feb 2022

New tool appears to accurately identify patients at risk of death from alcohol-associated hepatitis

Mayo Clinic researchers have developed a new scoring system to help health care professionals predict the 30-day mortality risk for patients with alcohol-associated hepatitis, and the tool appears to more accurately identify patients at highest risk of death and those likely to survive.

15 Feb 2022

Researchers generate stable cell lines capable of producing various hepatitis B virus genotypes

A new study created stable cell lines capable of producing different genotypes of the hepatitis B virus (HBV), advancing understanding of each type's distinct virological features, treatment responses, and infectivity that could lead to new therapies against a virus infecting humans as far back as 4,500 years ago.

15 Feb 2022

Liver News and Research

Study offers a new, effective therapeutic option against glioblastoma

Covid still threatens millions of Americans. Why are we so eager to move on?

Livers of men with hepatic diseases undergo sex-change

The logic that controls gene regulation in human cells discovered

Poll: Most parents have limited knowledge about CBD products for children

Treatment with direct-acting antivirals reduces emergency visits, hospitalizations among hepatitis C patients

Simplified model for describing biological tissue properties allows time and cost savings

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Intermediate size nanoparticles may be effective at stopping internal bleeding

Gut microbial signatures associated with increased risk of developing type 2 diabetes

Gut enzymes open a gateway to create universal blood-type donor organs

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Study uncovers most critical genes that cause coronary heart disease

New tool appears to accurately identify patients at risk of death from alcohol-associated hepatitis

Researchers generate stable cell lines capable of producing various hepatitis B virus genotypes

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

NYU Langone achieves top rankings for kidney transplants in New York City and the United States

Structural protein vimentin facilitates SARS-CoV-2 entry into endothelial cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News